|
Volume 271,
Number 13,
Issue of March 29, 1996 pp. 7602-7608
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
The Domain Organization of Human
Topoisomerase I
(Received for publication, October
12, 1995; and in revised form, January 21, 1996)
Lance
Stewart ,
Gregory C.
Ireton,
James
J.
Champoux
Using limited proteolysis, we show that the domain boundaries of
human topoisomerase I closely parallel those predicted from sequence
comparisons with other cellular Topo I enzymes. The enzyme is comprised
of (i) an NH -terminal domain ( 24 kDa), which is known
to be dispensable for activity, (ii) the core domain ( 54 kDa),
(iii) a linker region ( 3 kDa), and (iv) the COOH-terminal domain
( 10 kDa), which contains the active site tyrosine. The highly
conserved core and COOH-terminal domains are resistant to proteolysis,
while the unconserved NH -terminal and linker domains are
sensitive. Noncovalent binding of Topo I to plasmid DNA or to short
duplex oligonucleotides decreases the sensitivity of the linker to
proteolysis by approximately a factor of 10 but has no effect on
proteolysis of the NH -terminal domain. When the enzyme is
covalently complexed to an 18 base pair single-stranded
oligonucleotide, the linker region is sensitive to proteolysis whether
or not duplex DNA is present. The net positive charge of the linker
domain suggests that at a certain point in catalysis the linker may
bind directly to DNA. Further, we show that limited subtilisin cleavage
can generate a mixture of 60-kDa core and 10-kDa COOH-terminal
fragments, which retain a level of topoisomerase activity that is
nearly equal to undigested control samples, presumably because the two
fragments remain associated after proteolytic cleavage. Thus, despite
its potential role in DNA binding, the linker domain (in addition to
the NH -terminal domain) appears to be dispensable for
topoisomerase activity. Finally, the limited proteolysis pattern of the
human enzyme differs substantially from the limited proteolysis pattern
of the vaccinia viral Topo I, indicating that the two enzymes belong to
separate eukaryotic topoisomerase I subfamilies.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. M. Baker, R. Rajan, and A. Mondragon
Structural studies of type I topoisomerases
Nucleic Acids Res.,
February 1, 2009;
37(3):
693 - 701.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Palle, L. Pattarello, M. van der Merwe, C. Losasso, P. Benedetti, and M.-A. Bjornsti
Disulfide Cross-links Reveal Conserved Features of DNA Topoisomerase I Architecture and a Role for the N Terminus in Clamp Closure
J. Biol. Chem.,
October 10, 2008;
283(41):
27767 - 27775.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Chillemi, I. D'Annessa, P. Fiorani, C. Losasso, P. Benedetti, and A. Desideri
Thr729 in human topoisomerase I modulates anti-cancer drug resistance by altering protein domain communications as suggested by molecular dynamics simulations
Nucleic Acids Res.,
October 1, 2008;
36(17):
5645 - 5651.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. van der Merwe and M.-A. Bjornsti
Mutation of Gly721 Alters DNA Topoisomerase I Active Site Architecture and Sensitivity to Camptothecin
J. Biol. Chem.,
February 8, 2008;
283(6):
3305 - 3315.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. F. Frohlich, C. Veigaard, F. F. Andersen, A. K. McClendon, A. C. Gentry, A. H. Andersen, N. Osheroff, T. Stevnsner, and B. R. Knudsen
Tryptophane-205 of human topoisomerase I is essential for camptothecin inhibition of negative but not positive supercoil removal
Nucleic Acids Res.,
September 25, 2007;
35(18):
6170 - 6180.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Har-Vardi, R. Mali, M. Breietman, Y. Sonin, S. Albotiano, E. Levitas, G. Potashnik, and E. Priel
DNA topoisomerases I and II in human mature sperm cells: characterization and unique properties
Hum. Reprod.,
August 1, 2007;
22(8):
2183 - 2189.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Chillemi, A. Bruselles, P. Fiorani, S. Bueno, and A. Desideri
The open state of human topoisomerase I as probed by molecular dynamics simulation
Nucleic Acids Res.,
May 14, 2007;
35(9):
3032 - 3038.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Losasso, E. Cretaio, K. Palle, L. Pattarello, M.-A. Bjornsti, and P. Benedetti
Alterations in Linker Flexibility Suppress DNA Topoisomerase I Mutant-induced Cell Lethality
J. Biol. Chem.,
March 30, 2007;
282(13):
9855 - 9864.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Bowen, A. Stuart, J.-H. Ju, J. Tuan, J. Blonder, T. P. Conrads, T. D. Veenstra, and E. P. Gelmann
NKX3.1 Homeodomain Protein Binds to Topoisomerase I and Enhances Its Activity
Cancer Res.,
January 15, 2007;
67(2):
455 - 464.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Ganguly, B. B. Das, N. Sen, A. Roy, S. B. Dasgupta, and H. K. Majumder
'LeishMan' topoisomerase I: an ideal chimera for unraveling the role of the small subunit of unusual bi-subunit topoisomerase I from Leishmania donovani
Nucleic Acids Res.,
December 4, 2006;
34(21):
6286 - 6297.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Fiorani, G. Chillemi, C. Losasso, S. Castelli, and A. Desideri
The different cleavage DNA sequence specificity explains the camptothecin resistance of the human topoisomerase I Glu418Lys mutant
Nucleic Acids Res.,
October 6, 2006;
34(18):
5093 - 5100.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Yang, C.-T. Hsu, C.-Y. Ting, L. F. Liu, and J. Hwang
Assembly of a Polymeric Chain of SUMO1 on Human Topoisomerase I in Vitro
J. Biol. Chem.,
March 24, 2006;
281(12):
8264 - 8274.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Marchand, S. Antony, K. W. Kohn, M. Cushman, A. Ioanoviciu, B. L. Staker, A. B. Burgin, L. Stewart, and Y. Pommier
A novel norindenoisoquinoline structure reveals a common interfacial inhibitor paradigm for ternary trapping of the topoisomerase I-DNA covalent complex.
Mol. Cancer Ther.,
February 1, 2006;
5(2):
287 - 295.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Sari and I. Andricioaei
Rotation of DNA around intact strand in human topoisomerase I implies distinct mechanisms for positive and negative supercoil relaxation
Nucleic Acids Res.,
November 27, 2005;
33(20):
6621 - 6634.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Chillemi, P. Fiorani, S. Castelli, A. Bruselles, P. Benedetti, and A. Desideri
Effect on DNA relaxation of the single Thr718Ala mutation in human topoisomerase I: a functional and molecular dynamics study
Nucleic Acids Res.,
June 8, 2005;
33(10):
3339 - 3350.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. B. Das, N. Sen, S. B. Dasgupta, A. Ganguly, and H. K. Majumder
N-terminal Region of the Large Subunit of Leishmania donovani Bisubunit Topoisomerase I Is Involved in DNA Relaxation and Interaction with the Smaller Subunit
J. Biol. Chem.,
April 22, 2005;
280(16):
16335 - 16344.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Yu, E. Khan, M. A. Khaleque, J. Lee, G. Laco, G. Kohlhagen, S. Kharbanda, Y.-C. Cheng, Y. Pommier, and A. Bharti
Phosphorylation of DNA Topoisomerase I by the c-Abl Tyrosine Kinase Confers Camptothecin Sensitivity
J. Biol. Chem.,
December 10, 2004;
279(50):
51851 - 51861.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Q. Hu, N. Fertig, T. A. Medsger Jr, and T. M. Wright
Molecular Recognition Patterns of Serum Anti-DNA Topoisomerase I Antibody in Systemic Sclerosis
J. Immunol.,
August 15, 2004;
173(4):
2834 - 2841.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. O. Christensen, H. U. Barthelmes, F. Boege, and C. Mielke
Residues 190-210 of human topoisomerase I are required for enzyme activity in vivo but not in vitro
Nucleic Acids Res.,
December 15, 2003;
31(24):
7255 - 7263.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Roy, P. Trowbridge, Z. Yang, J. J. Champoux, and D. T. Simmons
The Cap Region of Topoisomerase I Binds to Sites near Both Ends of Simian Virus 40 T Antigen
J. Virol.,
September 15, 2003;
77(18):
9809 - 9816.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Bodley, A. K. Chakraborty, S. Xie, C. Burri, and T. A. Shapiro
An unusual type IB topoisomerase from African trypanosomes
PNAS,
June 24, 2003;
100(13):
7539 - 7544.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. F. Carey, S. J. Schultz, L. Sisson, T. G. Fazzio, and J. J. Champoux
DNA relaxation by human topoisomerase I occurs in the closed clamp conformation of the protein
PNAS,
May 13, 2003;
100(10):
5640 - 5645.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Villa, A. R. Otero Marcos, R. M. Reguera, R. Balana-Fouce, C. Garcia-Estrada, Y. Perez-Pertejo, B. L. Tekwani, P. J. Myler, K. D. Stuart, M.-A. Bjornsti, et al.
A Novel Active DNA Topoisomerase I in Leishmania donovani
J. Biol. Chem.,
January 31, 2003;
278(6):
3521 - 3526.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Rallabhandi, K. Hashimoto, Y.-Y. Mo, W. T. Beck, P. K. Moitra, and P. D'Arpa
Sumoylation of Topoisomerase I Is Involved in Its Partitioning between Nucleoli and Nucleoplasm and Its Clearing from Nucleoli in Response to Camptothecin
J. Biol. Chem.,
October 11, 2002;
277(42):
40020 - 40026.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D.-T. T. Lesher, Y. Pommier, L. Stewart, and M. R. Redinbo
8-Oxoguanine rearranges the active site of human topoisomerase I
PNAS,
September 17, 2002;
99(19):
12102 - 12107.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Takahashi, S. Matsuhara, M. Abe, and Y. Komeda
Disruption of a DNA Topoisomerase I Gene Affects Morphogenesis in Arabidopsis
PLANT CELL,
September 1, 2002;
14(9):
2085 - 2093.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Yang and J. J. Champoux
Reconstitution of Enzymatic Activity by the Association of the Cap and Catalytic Domains of Human Topoisomerase I
J. Biol. Chem.,
August 16, 2002;
277(34):
30815 - 30823.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. T. Van Dross and M. M. Sanders
Molecular Characterization of Recombinant Pneumocystis carinii Topoisomerase I: Differential Interactions with Human Topoisomerase I Poisons and Pentamidine
Antimicrob. Agents Chemother.,
July 1, 2002;
46(7):
2145 - 2154.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Mao, I. R. Mehl, and M. T. Muller
Subnuclear distribution of topoisomerase I is linked to ongoing transcription and p53 status
PNAS,
January 17, 2002;
(2002)
22631899.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Soe, G. Dianov, H.-P. Nasheuer, V. A. Bohr, F. Grosse, and T. Stevnsner
A human topoisomerase I cleavage complex is recognized by an additional human topisomerase I molecule in vitro
Nucleic Acids Res.,
August 1, 2001;
29(15):
3195 - 3203.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Zhang and F. Kiechle
Hoechst 33342-Induced Apoptosis is Associated with Decreased Immunoreactive Topoisomerase I and Topoisomerase I-DNA Complex Formation
Ann. Clin. Lab. Sci.,
April 1, 2001;
31(2):
187 - 198.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Balestrazzi, A. Chini, G. Bernacchia, A. Bracci, G. Luccarini, R. Cella, and D. Carbonera
Carrot cells contain two top1 genes having the coding capacity for two distinct DNA topoisomerases I
J. Exp. Bot.,
December 1, 2000;
51(353):
1979 - 1990.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-J. Chen, C.-L. Hwong, C.-H. Wang, and J. Hwang
Degradation of DNA Topoisomerase I by a Novel Trypsin-like Serine Protease in Proliferating Human T Lymphocytes
J. Biol. Chem.,
April 21, 2000;
275(17):
13109 - 13117.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Stewart, G. C. Ireton, and J. J. Champoux
A Functional Linker in Human Topoisomerase I Is Required for Maximum Sensitivity to Camptothecin in a DNA Relaxation Assay
J. Biol. Chem.,
November 12, 1999;
274(46):
32950 - 32960.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. L. Beretta, M. Binaschi, E. Zagni, L. Capuani, and G. Capranico
Tethering a Type IB Topoisomerase to a DNA Site by Enzyme Fusion to a Heterologous Site-selective DNA-binding Protein Domain
Cancer Res.,
August 1, 1999;
59(15):
3689 - 3697.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Komatani, M. Morita, N. Sakaizumi, K. Fukasawa, E. Yoshida, A. Okura, T. Yoshinari, and S. Nishimura
A New Mechanism of Acquisition of Drug Resistance by Partial Duplication of Topoisomerase I
Cancer Res.,
June 1, 1999;
59(11):
2701 - 2708.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. W. Trowbridge, R. Roy, and D. T. Simmons
Human Topoisomerase I Promotes Initiation of Simian Virus 40 DNA Replication In Vitro
Mol. Cell. Biol.,
March 1, 1999;
19(3):
1686 - 1694.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. C. Kampranis and A. Maxwell
Conformational Changes in DNA Gyrase Revealed by Limited Proteolysis
J. Biol. Chem.,
August 28, 1998;
273(35):
22606 - 22614.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-L. Shaiu and T.-s. Hsieh
Targeting to Transcriptionally Active Loci by the Hydrophilic N-Terminal Domain of Drosophila DNA Topoisomerase I
Mol. Cell. Biol.,
July 1, 1998;
18(7):
4358 - 4367.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
L. Stewart, M. R. Redinbo, X. Qiu, W. G. Hol, and J. J. Champoux
A Model for the Mechanism of Human Topoisomerase I
Science,
March 6, 1998;
279(5356):
1534 - 1541.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
B. E. Jones, V. Dossonnet, E. Kuster, W. Hillen, J. Deutscher, and R. E. Klevit
Binding of the Catabolite Repressor Protein CcpA to Its DNA Target Is Regulated by Phosphorylation of its Corepressor HPr
J. Biol. Chem.,
October 17, 1997;
272(42):
26530 - 26535.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. O. Petersen and S. Shuman
Histidine 265Is Important for Covalent Catalysis by Vaccinia Topoisomerase and Is Conserved in All Eukaryotic Type I Enzymes
J. Biol. Chem.,
February 14, 1997;
272(7):
3891 - 3896.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Stewart, G. C. Ireton, L. H. Parker, K. R. Madden, and J. J. Champoux
Biochemical and Biophysical Analyses of Recombinant Forms of Human Topoisomerase I
J. Biol. Chem.,
March 29, 1996;
271(13):
7593 - 7601.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. C. Ireton, L. Stewart, L. H. Parker, and J. J. Champoux
Expression of Human Topoisomerase I with a Partial Deletion of the Linker Region Yields Monomeric and Dimeric Enzymes That Respond Differently to Camptothecin
J. Biol. Chem.,
August 11, 2000;
275(33):
25820 - 25830.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-Y. Mo, C. Wang, and W. T. Beck
A Novel Nuclear Localization Signal in Human DNA Topoisomerase I
J. Biol. Chem.,
December 22, 2000;
275(52):
41107 - 41113.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Yang and J. J. Champoux
The Role of Histidine 632 in Catalysis by Human Topoisomerase I
J. Biol. Chem.,
January 5, 2001;
276(1):
677 - 685.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Lisby, J. R. Olesen, C. Skouboe, B. O. Krogh, T. Straub, F. Boege, S. Velmurugan, P. M. Martensen, A. H. Andersen, M. Jayaram, et al.
Residues within the N-terminal Domain of Human Topoisomerase I Play a Direct Role in Relaxation*
J. Biol. Chem.,
June 1, 2001;
276(23):
20220 - 20227.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-Y. Mo, Y. Yu, Z. Shen, and W. T. Beck
Nucleolar Delocalization of Human Topoisomerase I in Response to Topotecan Correlates with Sumoylation of the Protein
J. Biol. Chem.,
January 18, 2002;
277(4):
2958 - 2964.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Mao, I. R. Mehl, and M. T. Muller
Subnuclear distribution of topoisomerase I is linked to ongoing transcription and p53 status
PNAS,
February 5, 2002;
99(3):
1235 - 1240.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|